Drug profile · INN
valproate sodium
VALPROATE SODIUM
valproate sodium (VALPROATE SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — valproate sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
valproate sodium (VALPROATE SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Succinate semialdehyde dehydrogenase inhibitor
Primary target: Succinate-semialdehyde dehydrogenase, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is valproate sodium?
valproate sodium (VALPROATE SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for valproate sodium?
VALPROATE SODIUM is a marketed brand name for valproate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valproate sodium?
valproate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.